psilocybin drug metabolism

psilocybin drug metabolism

Avoid 3 Silent Psilocybin Prescription Medication Guide Traps

Clinicians avoid silent traps by systematically reviewing metabolic pathways, assessing CYP enzyme interactions, and tailoring dosing to individual pharmacogenetic profiles. In practice this means mapping each patient’s medication list against psilocybin’s biotransformation routes before the first dose. Approximately 7% of Caucasian patients are poor CYP2D6 metabolizers, a figure